-
1241
Key insights into recent advances and challenges in COVID-19 management
Published 2025-01-01Subjects: Get full text
Article -
1242
Unraveling HPV-associated cancer complexity: From molecular insights to innovative therapies
Published 2025-02-01Subjects: Get full text
Article -
1243
Cervical cancer mortality trends in England and Poland
Published 2024-12-01Subjects: Get full text
Article -
1244
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Published 2025-01-01Subjects: Get full text
Article -
1245
-
1246
Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?
Published 2024-12-01Subjects: “…Vaccine…”
Get full text
Article -
1247
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescentsResearch in context
Published 2025-01-01Subjects: Get full text
Article -
1248
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Published 2025-01-01Subjects: Get full text
Article -
1249
Stochastic epidemic models with a backward bifurcation
Published 2006-04-01Subjects: Get full text
Article -
1250
Medicinal products used for the treatment and prophylaxis of COVID-19
Published 2020-06-01Subjects: Get full text
Article -
1251
Spatial epidemiology based on the analysis of COVID-19 in Africa
Published 2025-03-01Subjects: Get full text
Article -
1252
Risk of hospitalization of diagnosed COVID-19 cases during the pandemic: A time-series analysis to unveil short- and long-run dynamics
Published 2024-03-01Subjects: Get full text
Article -
1253
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia
Published 2023-09-01“…Introduction People who are immunocompromised have a poor biological response to vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia (CLL) if a 3-week pause in Bruton tyrosine kinase inhibitor therapy (BTKi) starting 1 week before delivery of SARS-CoV-2 vaccine booster, improves vaccine immune response when compared with continuation of BTKi.Methods and analysis An open-label, randomised controlled superiority trial will be conducted in haematology clinics in approximately 10 UK National Health Service (NHS) hospitals. …”
Get full text
Article -
1254
Mass rabies exposure of veterinary health care workers in Germany: Management, immune response, and tolerability of post exposure-prophylaxis
Published 2025-06-01Subjects: Get full text
Article -
1255
Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars—Advice to Developers and Regulatory Agencies
Published 2025-01-01Subjects: Get full text
Article -
1256
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
Published 2025-01-01Subjects: Get full text
Article -
1257
A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges
Published 2018-01-01“…Here, we performed a comparative evaluation of the immunogenicity and protective efficacy of individual optimized VEEV, WEEV, and EEEV DNA vaccines with that of a 1 : 1 : 1 mixture of these vaccines, which we have termed the 3-EEV DNA vaccine, when delivered by IM EP. …”
Get full text
Article -
1258
-
1259
Bilim İletişimi ve Medya: İnternet Haber Sitelerinin Yerli Aşıya Yönelik İçerikleri Üzerine Bir İnceleme
Published 2022-12-01Subjects: Get full text
Article -
1260